Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,723 | -15,290 | -5,924 | -4,148 | -1,888 |
| Depreciation Amortization | 1 | 2,330 | 2,311 | 1,376 | 227 |
| Other Working Capital | -273 | -3,060 | -2,082 | -1,690 | -1,225 |
| Other Operating Activity | 1,179 | 10,810 | 1,699 | 1,487 | 1,094 |
| Operating Cash Flow | $-1,815 | $-5,210 | $-3,996 | $-2,975 | $-1,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | 0 | N/A | N/A | N/A |
| Investing Cash Flow | $-12 | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,524 | 3,425 | 3,425 | 2,150 |
| Debt Issued | N/A | 1,751 | 1,751 | 951 | 951 |
| Debt Repayment | -1,219 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,421 | 15,184 | N/A | N/A | N/A |
| Other Financing Activity | 55 | -759 | -990 | -832 | -323 |
| Financing Cash Flow | $1,256 | $19,700 | $4,186 | $3,543 | $2,778 |
| Beginning Cash Position | 14,571 | 80 | 81 | 81 | 81 |
| End Cash Position | 14,001 | 14,570 | 271 | 650 | 1,068 |
| Net Cash Flow | $-571 | $14,480 | $190 | $568 | $987 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,815 | -5,210 | -3,996 | -2,975 | -1,791 |
| Capital Expenditure | -12 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,827 | -5,210 | -3,996 | -2,975 | -1,791 |